Our Pricing

The Science Behind Acid Reflux Treatment

Understanding how do acid reflux treatments work UK is essential for choosing the right medication for your symptoms. At Cured Pharmacy, our UK-registered clinical team prescribes evidence-based treatments including proton pump inhibitors (PPIs) and H2 receptor antagonists, all backed by decades of clinical research and MHRA approval.

How Proton Pump Inhibitors (PPIs) Work

Proton pump inhibitors are the most effective class of acid reflux medication available in the UK, working by blocking the final step of gastric acid production in the stomach lining [1]. PPIs such as omeprazole, esomeprazole, lansoprazole, and pantoprazole irreversibly bind to the hydrogen-potassium ATPase enzyme system (the 'proton pump') in parietal cells, reducing acid secretion by up to 90% within 2-3 days [1][2].

Unlike antacids that simply neutralise existing acid, PPIs prevent acid production at the cellular level, providing sustained relief for up to 24 hours from a single daily dose [2]. This mechanism makes them particularly effective for treating gastro-oesophageal reflux disease (GORD), erosive oesophagitis, and preventing NSAID-induced ulcers.

Clinical trials demonstrate that PPIs heal oesophageal erosions in approximately 80-90% of patients within 8 weeks, significantly higher than H2 receptor antagonists at around 50-60% [3]. At Cured Pharmacy, we offer multiple PPI options including Omeprazole Capsules from £9.99, allowing our UK prescribers to tailor treatment to your specific symptoms and medical history.

Why PPIs Take Time to Work

Many patients expect immediate relief from PPIs, but understanding their mechanism explains why they require 1-3 days to reach full effectiveness. Because PPIs must accumulate in the acidic environment of parietal cells and irreversibly bind to newly formed proton pumps, symptom improvement is gradual rather than instant [1]. Taking your PPI 30-60 minutes before breakfast optimises absorption and ensures the medication reaches peak concentration when proton pumps are most active.

Comparing Different PPI Medications

While all PPIs share the same fundamental mechanism, subtle differences in their chemical structure affect their onset of action, duration, and interaction with other medications [2]. Esomeprazole, the S-isomer of omeprazole, demonstrates more predictable pharmacokinetics and may provide slightly superior acid suppression in some patients [4].

Lansoprazole and pantoprazole are alternatives for patients who experience side effects with omeprazole or require different dosing schedules. Lansoprazole is available as Zoton Fastabs from £9.99, which dissolve on the tongue without water—particularly useful for patients with swallowing difficulties. Pantoprazole shows fewer drug interactions with medications metabolised by the CYP2C19 enzyme, making it preferable for patients on multiple medications [2].

Our superintendent pharmacist Tarun Kumar (GPhC 2233073) and clinical team assess your complete medication profile during consultation to identify the most suitable PPI for your individual circumstances, all subject to prescriber approval.

H2 Receptor Antagonists: An Alternative Approach

H2 receptor antagonists (H2RAs) such as famotidine and ranitidine work through a different mechanism than PPIs, blocking histamine H2 receptors on parietal cells to reduce acid secretion by approximately 60-70% [3]. While less potent than PPIs, H2RAs offer faster onset of action—typically within 30-60 minutes—making them suitable for on-demand relief of mild to moderate symptoms.

H2RAs are particularly effective for nocturnal acid breakthrough, a phenomenon where acid secretion increases during sleep despite daytime PPI use [3]. Some patients benefit from combination therapy, taking a PPI in the morning and an H2RA at bedtime, though this approach requires careful clinical assessment.

The key limitation of H2RAs is tachyphylaxis—reduced effectiveness with continuous use as the body upregulates alternative acid secretion pathways [3]. For this reason, UK prescribers typically recommend PPIs for long-term GORD management, reserving H2RAs for intermittent symptoms or specific clinical scenarios.

When H2 Blockers Are Preferred

Certain patient groups may benefit more from H2 receptor antagonists than PPIs. Pregnant women experiencing reflux symptoms often receive H2RAs as first-line treatment due to their longer safety record, though both classes are considered relatively safe in pregnancy subject to prescriber assessment [3]. Patients requiring only occasional symptom relief may prefer H2RAs to avoid the delayed onset associated with PPIs.

Understanding Gastric Acid Physiology

To appreciate how acid reflux treatments work, it's essential to understand normal gastric acid production. Parietal cells in the stomach lining secrete hydrochloric acid through three primary pathways: histamine (H2 receptors), gastrin (CCK-B receptors), and acetylcholine (muscarinic M3 receptors) [1]. These pathways converge on the proton pump, which exchanges potassium ions for hydrogen ions to create the acidic environment necessary for digestion.

In GORD, the lower oesophageal sphincter fails to prevent stomach contents from refluxing into the oesophagus, exposing sensitive oesophageal tissue to acid and pepsin [4]. This exposure causes the characteristic burning sensation and, over time, can lead to oesophageal inflammation, erosions, Barrett's oesophagus, and in rare cases, oesophageal adenocarcinoma.

By reducing gastric acid production through PPI or H2RA therapy, we allow the oesophageal mucosa to heal whilst reducing symptom frequency and severity [4]. However, medication alone rarely addresses the underlying mechanical dysfunction—lifestyle modifications including weight management, dietary changes, and sleeping position adjustments remain essential components of comprehensive GORD management.

Optimising PPI Therapy for Maximum Effectiveness

Many patients experience suboptimal results from PPI therapy due to incorrect timing or dosing rather than treatment failure [2]. PPIs require an acidic environment to become activated and work best when taken 30-60 minutes before the first meal of the day, when proton pumps are most actively secreting acid. Taking PPIs at bedtime or with food significantly reduces their effectiveness.

For patients with persistent symptoms despite standard-dose PPI therapy, UK prescribers may consider dose escalation or twice-daily dosing rather than switching medication classes immediately [2]. Approximately 10-20% of GORD patients require higher doses or twice-daily administration to achieve adequate acid suppression, particularly those with severe erosive disease or Barrett's oesophagus [4].

Our online consultation process at Cured Pharmacy includes detailed questions about your symptom pattern, current medication timing, and previous treatment responses. This information allows our UK-registered prescribers to optimise your PPI regimen from the outset, improving the likelihood of symptom resolution. All prescription medications require clinical assessment by a UK prescriber before dispensing.

Addressing PPI Non-Response

True PPI-refractory GORD affects approximately 10-15% of patients and requires careful evaluation to exclude non-acid reflux, functional heartburn, or alternative diagnoses such as eosinophilic oesophagitis [4]. If you've tried multiple PPIs without adequate relief, your prescriber may recommend diagnostic testing including pH monitoring or endoscopy before adjusting therapy. At Cured Pharmacy, we work collaboratively with your NHS GP when additional investigations are warranted.

Long-Term PPI Use: Benefits and Considerations

PPIs have been used safely for over three decades, with millions of patients taking them long-term for chronic GORD, Barrett's oesophagus, and peptic ulcer prevention [1]. Clinical guidelines from NICE support continuous PPI therapy for patients with confirmed erosive oesophagitis or complicated GORD, typically at the lowest effective dose.

Recent observational studies have suggested potential associations between long-term PPI use and outcomes including osteoporotic fractures, vitamin B12 deficiency, hypomagnesaemia, and Clostridium difficile infection [2][4]. However, these studies demonstrate correlation rather than causation, and the absolute risk increases remain small. For most patients, the proven benefits of PPI therapy in preventing oesophageal complications substantially outweigh theoretical risks.

Our approach at Cured Pharmacy involves regular medication reviews to ensure you're taking the minimum effective dose for symptom control. Some patients can successfully step down to on-demand therapy or lower doses after initial healing, whilst others require continuous treatment to prevent symptom recurrence. Your UK prescriber will discuss the risk-benefit profile specific to your clinical situation during consultation, ensuring you make an informed decision about long-term management.

Scientific References

1. Shin, J. M., & Sachs, G. (2008). Pharmacology of proton pump inhibitors. Current Gastroenterology Reports, 10(6), 528-534. https://doi.org/10.1007/s11894-008-0098-4
2. Strand, D. S., Kim, D., & Peura, D. A. (2017). 25 Years of Proton Pump Inhibitors: A Comprehensive Review. Gut and Liver, 11(1), 27-37. https://doi.org/10.5009/gnl15502
3. National Institute for Health and Care Excellence. (2014). Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (CG184). NICE.
4. Katz, P. O., Gerson, L. B., & Vela, M. F. (2013). Guidelines for the diagnosis and management of gastroesophageal reflux disease. American Journal of Gastroenterology, 108(3), 308-328. https://doi.org/10.1038/ajg.2012.444

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.